FRCPath Haem Part 1 MCQ-Haemostasis 360

A pt with immune TTP completes plasma exchange and is clinically stable. ADAMTS13 activity: <10 IU/dL. What is most appropriate management of Caplacizumab?

• Stop after last session of plasma exchange
• Stop once plasma count normalizes
• Switch to Aspirin
• Continue till ADAMTS13 recovers

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now